| Index | — | P/E | 17.08 | EPS (ttm) | 2.68 | Insider Own | 2.06% | Shs Outstand | 38.73M | Perf Week | -6.59% |
| Market Cap | 1.77B | Forward P/E | 48.73 | EPS next Y | 0.94 | Insider Trans | -0.46% | Shs Float | 38.34M | Perf Month | 24.95% |
| Enterprise Value | 2.18B | PEG | — | EPS next Q | 0.23 | Short Float | 9.99% | Perf Quarter | 37.65% | ||
| Income | 104.00M | P/S | 0.52 | EPS this Y | 133.68% | Short Ratio | 5.73 | Perf Half Y | 120.90% | ||
| Sales | 3.43B | P/B | 2.39 | EPS next Y | -71.44% | ROA | 4.44% | Short Interest | 3.83M | Perf YTD | 190.42% |
| Book/sh | 19.13 | P/C | 4.90 | EPS next 5Y | -38.04% | ROE | 15.31% | 52W High | 49.62 -7.76% | Perf Year | 135.81% |
| Cash/sh | 9.35 | P/FCF | 4.03 | EPS past 3/5Y | — | ROIC | 6.42% | 52W Low | 14.97 205.74% | Perf 3Y | -39.48% |
| Dividend Est. | — | EV/EBITDA | 6.30 | Sales past 3/5Y | -19.55% 2.66% | Gross Margin | 27.79% | Volatility | 4.85% 4.64% | Perf 5Y | -52.76% |
| Dividend TTM | — | EV/Sales | 0.64 | EPS Y/Y TTM | — | Oper. Margin | 4.68% | ATR (14) | 1.89 | Perf 10Y | 37.24% |
| Dividend Ex-Date | Sep 29, 2011 | Quick Ratio | 1.13 | Sales Y/Y TTM | 23.89% | Profit Margin | 3.06% | RSI (14) | 67.77 | Recom | 2.47 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.13 | EPS Q/Q | 156.67% | SMA20 | 9.17% | Beta | 0.45 | Target Price | 37.75 |
| Payout | 0.00% | Debt/Eq | 1.04 | Sales Q/Q | 2.28% | SMA50 | 22.25% | Rel Volume | 1.29 | Prev Close | 47.11 |
| Employees | 2,664 | LT Debt/Eq | 1.04 | Earnings | Nov 05 | SMA200 | 60.07% | Avg Volume | 754.65K | Price | 45.77 |
| IPO Date | Nov 13, 2001 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 307.77% 7.13% | Net Debt/EBITDA | 1.18 | Volume | 971,290 | Change | -2.84% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-09-26 | Reiterated | BMO Capital | Outperform | $40 → $43 |
| Sep-11-26 | Reiterated | BMO Capital | Outperform | $26 → $40 |
| Aug-07-26 | Reiterated | Robert W. Baird | $26 → $36 | |
| Jul-22-26 | Reiterated | Truist Securities | Buy | $26 → $40 |
| May-13-26 | Reiterated | UBS | Neutral | $20 → $32 |
| May-11-26 | Reiterated | Robert W. Baird | $23 → $26 | |
| May-11-26 | Reiterated | BMO Capital | Outperform | $22 → $26 |
| May-08-26 | Reiterated | Truist Securities | Buy | $24 → $26 |
| Feb-20-26 | Reiterated | Robert W. Baird | $21 → $23 | |
| Feb-20-26 | Reiterated | UBS | Neutral | $20 |
AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,433 | 2,730 | 2,984 | 3,789 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,480 | 1,956 | 2,064 | 2,540 | — | — | — | — | — | |
| Gross Profit | 954 | 774 | 919 | 1,250 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 656 | 593 | 632 | 756 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 138 | 148 | 390 | 155 | — | — | — | — | — | |
| Operating Income | 160 | 33 | -103 | 338 | — | — | — | — | — | |
| Interest Expense | 36 | 46 | 70 | 54 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 39 | -89 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 164 | -101 | -173 | 284 | — | — | — | — | — | |
| Income Taxes | 60 | -5 | -26 | 74 | — | — | — | — | — | |
| Consolidated Net Income | 104 | -96 | -147 | 211 | — | — | — | — | — | |
| Net Income From Continuing Operations | 104 | -96 | -147 | 211 | — | — | — | — | — | |
| Net Income | 104 | -96 | -147 | 211 | — | — | — | — | — | |
| EPS (Recurring) | 2.70 | -2.48 | -3.85 | 5.38 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.70 | -2.48 | -3.85 | 5.38 | — | — | — | — | — | |
| EPS (Diluted) | 2.68 | -2.48 | -3.85 | 5.36 | — | — | — | — | — | |
| EBITDA | 346 | 101 | 71 | 499 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 17.08 | — | — | 13.97 | — | — | — | — | — | |
| Price To Sales Ratio | 0.52 | 0.23 | 0.30 | 0.77 | — | — | — | — | — | |
| Gross Margin | 27.79 | 28.35 | 30.80 | 32.99 | — | — | — | — | — | |
| Operating Margin | 4.66 | 1.21 | -3.45 | 8.92 | — | — | — | — | — | |
| Net Margin | 3.03 | -3.52 | -4.93 | 5.57 | — | — | — | — | — | |
| Shares Outstanding | 39 | 39 | 38 | 39 | — | — | — | — | — | |
| Market Capitalization | 1,785 | 615 | 909 | 2,920 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Laughlin Whitney M | Chief Legal Officer | Oct 15 '26 | Option Exercise | 0.00 | 4,976 | 0 | 29,004 | Oct 15 |
| Hagan Mark Christopher | Chief Information and Digital | Oct 15 '26 | Option Exercise | 0.00 | 9,331 | 0 | 54,204 | Oct 15 |
| Laughlin Whitney M | Chief Legal Officer | Sep 15 '26 | Option Exercise | 0.00 | 498 | 0 | 24,150 | Sep 16 |
| Jones Daphne E | Director | May 01 '26 | Option Exercise | 0.00 | 16,650 | 0 | 17,124 | Jul 09 |
| FOLETTA MARK G | Director | Jun 15 '26 | Sale | 31.07 | 3,681 | 114,362 | 17,917 | Jun 17 |
| FOLETTA MARK G | Director | May 01 '26 | Option Exercise | 0.00 | 8,325 | 0 | 21,598 | May 04 |
| Caballero Jorge A. | Director | May 01 '26 | Option Exercise | 0.00 | 8,325 | 0 | 15,462 | May 04 |
| Trent-Adams Sylvia | Director | May 01 '26 | Option Exercise | 0.00 | 8,325 | 0 | 16,797 | May 04 |
| HARRIS R JEFFREY | Director | May 01 '26 | Option Exercise | 0.00 | 43,063 | 0 | 102,000 | May 04 |
| Grace Caroline | Chief Executive Officer | Jan 15 '26 | Option Exercise | 0.00 | 41,131 | 0 | 87,877 | Jan 20 |
| Laughlin Whitney M | Chief Legal Officer | Jan 15 '26 | Option Exercise | 0.00 | 4,488 | 0 | 24,701 | Jan 16 |
| Hagan Mark Christopher | Chief Information and Digital | Jan 15 '26 | Option Exercise | 0.00 | 10,313 | 0 | 47,495 | Jan 16 |
| Scott Brian M. | CFO/COO | Jan 15 '26 | Option Exercise | 0.00 | 8,843 | 0 | 16,685 | Jan 16 |
| Scott Brian M. | CFO/COO | Dec 15 '25 | Option Exercise | 0.00 | 12,212 | 0 | 12,212 | Dec 15 |
| Grace Caroline | Chief Executive Officer | Nov 28 '25 | Option Exercise | 0.00 | 8,328 | 0 | 51,997 | Dec 02 |